Variable names | Category | Coefficient | S.E | ϕ | 95% CI | P-value |
---|---|---|---|---|---|---|
Sex | Female(ref.) | 1.00 | ||||
Male | − 0.079 | 0.033 | 0.924 | [0.866, 0.984] | 0.014* | |
Age | < 1 month | |||||
1–12 months | 0.340 | 0.213 | 1.405 | [0.926, 2.133] | 0.110 | |
13–36 months | 0.323 | 0.215 | 1.381 | [0.906, 2.105] | 0.130 | |
37–60 months | 0.299 | 0.219 | 1.349 | [0.878, 2.072] | 0.170 | |
> 60 months | 0.484 | 0.215 | 1.623 | [1.065,2.4747] | 0.024* | |
Vaccination status | No vaccinated(ref.) | |||||
Yes vaccinated | − 0.109 | 0.037 | 0.898 | [0.834, 0.965] | 0.003* | |
Presence of comorbidity | Yes (ref.) | |||||
No | 0.087 | 0.033 | 1.098 | [1.022, 1.164] | 0.008* | |
Breast feeding of patients | Yes (ref.) | |||||
No | 0.484 | 0.215 | 0.616 | (0.404, 0.939) | 0.024* | |
Drug regime | Ceftriaxone plus vancomycin | |||||
Ceftrazidime plus vancomycin | − 0.045 | 0.066 | 0.956 | (0.839, 1.089) | 0.500 | |
Ceftriaxone plus dexamethasone | − 0.070 | 0.042 | 0.932 | (0.850, 1.012) | 0.092 | |
Cefoperatone plus sulbactan | − 0.064 | 0.104 | 0.938 | (0.765, 1.151) | 0.450 | |
Ciprooxacin plus ceftriaxone | − 0.135 | 0.296 | 0.874 | (0.489, 1.559) | 0.650 | |
Ampicillin plus gentamycin | − 0.128 | 0.052 | 0.880 | (0.795, 0.974) | 0.013* | |
Others | 0.060 | 0.116 | 1.062 | (0.846, 1.332) | 0.600 | |
Constant | 2.330 | 0.215 | 10.282 | (6.742, 15.680) | 0.000 |